News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Pomerantz Roger
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/18/2023 |
4
| Pomerantz Roger (Director) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $1.23, valued at
$18.5k
|
|
| 06/09/2023 |
4
| Pomerantz Roger (Director) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $1.5, valued at
$60k
|
|
| 05/26/2023 |
4
| Pomerantz Roger (Director) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Exercised 9,035 restricted stock units
@ $0 |
|
| 02/28/2023 |
4
| Pomerantz Roger (Director) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Exercised 9,034 restricted stock units
@ $0 |
|
| 11/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/29/2022 |
4
| Pomerantz Roger (Director) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Exercised 9,034 restricted stock units
@ $0 |
|
| 08/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2022 |
4
| Pomerantz Roger (CEO) has filed a Form 4 on CONTRAFECT Corp|
Txns:
| Granted 500,000 options to buy
@ $3.33, valued at
$1.7M
|
|
| 11/29/2021 |
4
| Pomerantz Roger (Director) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Exercised 18,068 restricted stock units
@ $0 |
|
| 08/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2021 |
3
| Pomerantz Roger (Director) has filed a Form 3 on Intec Parent Inc. |
| 04/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2019 |
4
| Pomerantz Roger (Director) has filed a Form 4 on Intec Pharma Ltd.|
Txns:
| Granted 20,000 options to buy
@ $4.858, valued at
$97.2k
|
|
| 06/14/2019 |
4
| Pomerantz Roger (Director) has filed a Form 4 on Seres Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $2.83, valued at
$42.5k
|
|
| 04/04/2019 |
4
| Pomerantz Roger (CEO) has filed a Form 4 on CONTRAFECT Corp |
| 01/02/2019 |
3
| Pomerantz Roger (Director) has filed a Form 3 on Intec Pharma Ltd. |
| 09/11/2018 |
4
| Pomerantz Roger (President and CEO) has filed a Form 4 on Seres Therapeutics, Inc.|
Txns:
| Sold 1,810 shares
@ $9.0007, valued at
$16.3k
|
|
| 09/06/2018 |
4
| Pomerantz Roger (President and CEO) has filed a Form 4 on Seres Therapeutics, Inc.|
Txns:
| Sold 9,505 shares
@ $9.123, valued at
$86.7k
Sold 3,013 shares
@ $9.0393, valued at
$27.2k
|
|
| 07/23/2018 |
4
| Pomerantz Roger (Director) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Bought 100 shares
@ $23, valued at
$2.3k
|
|
| 07/18/2018 |
4
| Pomerantz Roger (Director) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $23, valued at
$575k
|
|
| 07/17/2018 |
3
| Pomerantz Roger (Director) has filed a Form 3 on Rubius Therapeutics, Inc. |
| 07/12/2018 |
4
| Pomerantz Roger (President and CEO) has filed a Form 4 on Seres Therapeutics, Inc.|
Txns:
| Sold 1,010 shares
@ $9.0089, valued at
$9.1k
Exercised 1,010 options to buy
@ $0.71, valued at
$717.1 |
|
| 07/10/2018 |
4
| Pomerantz Roger (President and CEO) has filed a Form 4 on Seres Therapeutics, Inc.|
Txns:
| Sold 15,366 shares
@ $9.144, valued at
$140.5k
Sold 10,981 shares
@ $9.1386, valued at
$100.4k
Sold 5,989 shares
@ $9.0512, valued at
$54.2k
Exercised 15,366 options to buy
@ $0.71, valued at
$10.9k
Exercised 10,981 options to buy
@ $0.71, valued at
$7.8k
Exercised 5,989 options to buy
@ $0.71, valued at
$4.3k
|
|
| 06/29/2018 |
4
| Pomerantz Roger (President and CEO) has filed a Form 4 on Seres Therapeutics, Inc.|
Txns:
| Sold 21,560 shares
@ $9.1547, valued at
$197.4k
Sold 4,496 shares
@ $9.1004, valued at
$40.9k
Exercised 21,560 options to buy
@ $0.71, valued at
$15.3k
Exercised 4,496 options to buy
@ $0.71, valued at
$3.2k
|
|
| 06/27/2018 |
4
| Pomerantz Roger (President and CEO) has filed a Form 4 on Seres Therapeutics, Inc.|
Txns:
| Sold 26,752 shares
@ $9.2144, valued at
$246.5k
Sold 21,224 shares
@ $9.194, valued at
$195.1k
Sold 16,991 shares
@ $9.0288, valued at
$153.4k
Exercised 16,288 options to buy
@ $0.71, valued at
$11.6k
Exercised 21,224 options to buy
@ $0.71, valued at
$15.1k
Exercised 16,991 options to buy
@ $0.71, valued at
$12.1k
|
|
| 06/22/2018 |
4
| Pomerantz Roger (President and CEO) has filed a Form 4 on Seres Therapeutics, Inc.|
Txns:
| Sold 26,492 shares
@ $9.3255, valued at
$247.1k
Sold 18,987 shares
@ $9.0638, valued at
$172.1k
Sold 40,057 shares
@ $9.3557, valued at
$374.8k
|
|
|
|
|